Introduction: Apparent diffusion coefficient (ADC) measures have been used in various tumour analyses and of particular importance here, ADC has been used as a biomarker for inferring tumour cellularity [1]. Increased tumour cellular densities as well as increased nuclear to cytoplasm ratios are believed to restrict diffusion of water molecules and hence imply a lower ADC value [2]. We investigated a previously described ADC measure [3,4,5], the Apparent Transient Coefficient in the Tumour (ATCT), to study whether it correlates with survival outcome in childhood embryonal brain tumours. The ATCT is a measure of the gradient change of ADC from the peri-tumoural oedema into the tumour core.
Figure 1: (a) Method for ATCT measurement: The oedema-tumour boundary is identified as marked by the blue contour. The white matter (WM), peritumoural oedema (O) and tumour core (T) are also shown. In order to measure the ATCT, the slice with the largest visible tumour area was selected. The ATCT is measured at 4 different locations using a 2 voxel width as shown by the voxels highlighted in green. The gradient change in ADC is calculated by applying a linear fit to the ADC values for the vertical column of four pixels on the left, at the posterior side of the tumour and circled in green. The gradient change in ADC is measured in all eight locations and the mean of these is the ATCT. 
